Last updated on July 2019

FLASH [Fluorescent Light Activated Synthetic Hypericin] Clinical Study: Topical SGX301 (Synthetic Hypericin) for the Treatment of Cutaneous T-Cell Lymphoma (Mycosis Fungoides)


Brief description of study

To evaluate the use of SGX301, a topical photosensitizing agent, to treat patients with patch/plaque phase cutaneous T-cell lymphoma (mycosis fungoides).

Clinical Study Identifier: NCT02448381

Find a site near you

Start Over

Seattle Care Cancer Center

Seattle, WA United States
  Connect »

Northwestern University

Chicago, IL United States
  Connect »

University of Arkansas

Little Rock, AR United States
  Connect »

Therapeutics Clinical Research

San Diego, CA United States
  Connect »

Olympian Clinical Research

Clearwater, FL United States
  Connect »

University of Arizona

Phoenix, AZ United States
  Connect »

Rush University

Chicago, IL United States
  Connect »

Tulane University

New Orleans, LA United States
  Connect »

Stanford University

Palo Alto, CA United States
  Connect »

PMG Research of Wilmington

Wilmington, NC United States
  Connect »

Stony Brook Medicine

Stony Brook, NY United States
  Connect »

University of Maryland

Baltimore, MD United States
  Connect »

Dawes Fretzin Dermatology Group

Indianapolis, IN United States
  Connect »

Vanderbilt University

Nashville, TN United States
  Connect »

Jefferson Dermatology

Philadelphia, PA United States
  Connect »

Mayo Clinic

Scottsdale, AZ United States
  Connect »

MD Anderson

Houston, TX United States
  Connect »

City of Hope

Duarte, CA United States
  Connect »

Washington University

Saint Louis, MO United States
  Connect »

Leon Medical Research

Miami, FL United States
  Connect »

Virginia Clinical Research

Norfolk, VA United States
  Connect »

University of Minnesota

Minneapolis, MN United States
  Connect »